Zimbabwe has declined a significant US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' insistence on confidential data.
This move came to light following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesperson has since stated that the United States was requesting health data for scientific study and commercial purposes but refused to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued negotiations to secure a deal agreeable to both sides so the country's vital HIV programme can proceed.
Wider Background
This rejection comes after a comparable situation in Kenya, where a high court halted a similar deal with the US after concerns were raised about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and accountability.
As per statements, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.
"Effectively, our nation would provide the raw materials for medical research with no assurance that the end products would be accessible to our population should a new pandemic emerge."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks already established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This mechanism is intended to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration could be structured in a way that honours the independence and interests of each country."
Medical Community Response
Medical experts stated it recognised the government's concerns, but recommended that talks should continue considering much of the nation's Aids initiatives were funded by foreign aid.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
This impasse highlights the continuing debate between accepting vital foreign assistance and protecting local interests in an increasingly data-driven world.